cardiovascular

New study by universities of Helsinki and Turku underlines the importance of higher education in dementia prevention

(PRESS RELEASE) HELSINKI, 7-Feb-2022 — /EuropaWire/ — University of Helsinki, the oldest and largest institution of academic education in Finland,…

2 years ago

MEDIS medical imaging systems acquires Advanced Medical Imaging Development S.r.l. (AMID) and secures further investment from Van Herk Ventures

(PRESS RELEASE) LEIDEN, Netherlands, 11-May-2020 — /EuropaWire/ — MEDIS, a leading developer and supplier of software applications for image-based diagnosis…

4 years ago

Medis to Launch an Innovative 4D Flow Module for Clinical Practice

Further enhances capabilities of Medis Suite MR to reduce complexity, simplify workflow and save time (PRESS RELEASE) LEIDEN, Netherlands, 1-Nov-2019…

4 years ago

University of Liverpool and Liverpool Heart and Chest Hospital NHS Foundation Trust appoint Professor Gregory Lip to lead new Liverpool Centre for Cardiovascular Science

LIVERPOOL, 18-Jun-2018 — /EuropaWire/ — The University of Liverpool and Liverpool Heart and Chest Hospital NHS Foundation Trust have appointed…

6 years ago

ESC statement on inflammation in atherosclerosis: more evidence needed before anti-inflammatory drugs can join statins as standard treatment

SOPHIA ANTIPOLIS, 15-May-2018 — /EuropaWire/ — A European Society of Cardiology (ESC) consensus statement on inflammation in atherosclerosis is published today…

6 years ago

Luxembourg Institute of Health: researchers identified a circular RNA that can predict patient outcome after heart attack

Researchers from LIH’s Cardiovascular Research Unit and international collaborators published an article in the number one cardiology journal, Journal of…

8 years ago

Loughborough University to receive part of UK’s health research investment on cardiovascular, respiratory and lifestyle conditions

Leicestershire, UK, 20-Sep-2016 — /EuropaWire/ — Loughborough University is to receive a slice of the UK’s largest ever investment into health…

8 years ago

AstraZeneca to present scientific abstracts from its cardiovascular and metabolic disease portfolio at European Society of Cardiology (ESC) Congress 2015 in London

LONDON, 31-8-2015 — /EuropaWire/ — Over 20 scientific abstracts from AstraZeneca’s cardiovascular and metabolic disease portfolio will be presented at…

9 years ago

SAVOR-TIMI-53 cardiovascular outcomes trial of ONGLYZA® results announced by AstraZeneca and Bristol-Myers Squibb

20-6-2013 — /europawire.eu/ — AstraZeneca and Bristol-Myers Squibb announced today top-line results of the Phase IV SAVOR-TIMI-53 (Saxagliptin Assessment of Vascular…

11 years ago